M&A

Bristol-Myers Squibb: Losing Otezla Might Be Challenging
Market Realist
Tue, 06/25/19 - 09:28 am
Bristol-Myers Squibb
Celgene
M&A
Otezla
AbbVie to acquire Allergan for $63 billion in megamerger of pharma giants
Stat
Tue, 06/25/19 - 09:18 am
AbbVie
Allergan
M&A
Humira
In surprise switch, Bristol-Myers is selling off blockbuster Otezla, promising to complete Celgene acquisition — just later
Endpoints
Mon, 06/24/19 - 11:23 am
Bristol-Myers Squibb
Opdivo
Otezla
M&A
FTC
Celgene
These 3 Biotech Stocks Skyrocketed Last Week
Motley Fool
Mon, 06/24/19 - 09:42 am
Array Biopharma
Pfizer
M&A
G1 Therapeutics
trilaciclib
Cel-Sci
Hologic Sets M&A Sights on SuperSonic Imagine in $85M Deal
Medical Devices and Diagnostics Industry
Fri, 06/21/19 - 11:37 pm
Hologic
M&A
SuperSonic Imagine
devices
breast imaging
What Should Celgene's Investors Do With Everything Bristol-Meyer Squibb Is Giving Them?
Motley Fool
Thu, 06/20/19 - 10:49 am
Bristol-Myers Squibb
Celgene
M&A
Pharmacquired: Is $11B enough to secure Sanofi's spot in hemophilia?
Biopharma Dive
Thu, 06/20/19 - 10:04 am
Sanofi
M&A
Bioverativ
hemophilia
gene therapy
GSK consumer health sell-off ahead of Pfizer joint venture
Pharmaforum
Thu, 06/20/19 - 09:54 am
GSK
M&A
Pfizer
consumer health
Investor day prep at Merck includes a new strategy to pick up the pace on M&A
Endpoints
Wed, 06/19/19 - 10:12 am
Merck
investors
Keytruda
cancer
M&A
Array-size deals don’t come around too often
EP Vantage
Tue, 06/18/19 - 11:34 pm
M&A
Pfizer
Array Biopharma
3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal
Motley Fool
Tue, 06/18/19 - 11:54 am
Pfizer
Array Biopharma
M&A
Amgen
Gilead Sciences
Biogen
Zoll Acquires TherOx for Undisclosed Sum
Medical Devices and Diagnostics Industry
Tue, 06/18/19 - 10:31 am
ZOLL Medical
devices
TherOx
M&A
Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon
Motley Fool
Mon, 06/17/19 - 11:28 pm
Pfizer
Array Biopharma
M&A
Pfizer Nabs Array Biopharma in $11.4 Billion Takeover of Cancer Drug Specialist
TheStreet.com
Mon, 06/17/19 - 10:20 am
Pfizer
Array Biopharma
M&A
cancer
colorectal cancer
Dr. Reddy’s to sell neurology branded products to Upsher-Smith Laboratories
Pharmaceutical Business Review
Mon, 06/17/19 - 09:52 am
Dr Reddy's
M&A
Upsher-Smith
neurology
Cue the M&A chatter: UniQure is scouting for a buyout deal as gene therapy field sizzles — report
Endpoints
Sun, 06/16/19 - 11:19 pm
uniQure
M&A
gene therapy
Merck's Full Court Press On Oncology
Forbes
Fri, 06/14/19 - 06:22 pm
Merck
oncology
R&D
M&A
Tilos Therapeutics
Dassault Puts Down $5.8B for Medidata Solutions
Medical Devices and Diagnostics Industry
Thu, 06/13/19 - 10:04 am
Dassault Systemes
Medidata Solutions
M&A
clinical trials
devices
FTC demands could mean months-long delay for Roche-Spark deal
Biopharma Dive
Wed, 06/12/19 - 06:44 pm
Roche
Spark Therapeutics
FTC
M&A
Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout
Endpoints
Mon, 06/10/19 - 07:38 pm
Spark Therapeutics
Roche
FTC
UK
M&A

Pages